SABRINA J WYLLIE-ADAMS
Allopathic & Osteopathic Physicians|Family Medicine STOCKBRIDGE, GA NPI 1548428519
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine GA Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$743.31
- Category: General Payments
- Program years: PY2018–2024
- Record count: 44
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $194.47 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.47 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $51.47 | 2 |
| DEXCOM, INC. | $43.67 | 2 |
| Novo Nordisk AS | $38.01 | 2 |
| Lilly USA, LLC | $27.48 | 1 |
| Acerta Pharma LLC | $18.18 | 1 |
| Amgen Inc. | $15.66 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089499930 | Daiichi Sankyo Inc. | $28.12 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089499932 | Daiichi Sankyo Inc. | $23.35 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097360245 | Novo Nordisk Inc | $18.80 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097391304 | Novo Nordisk Inc | $19.21 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104399037 | AstraZeneca Pharmaceuticals LP | $18.18 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117722514 | Amgen Inc. | $15.66 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135409875 | Lilly USA, LLC | $27.48 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153333239 | Dexcom, Inc. | $22.22 | 02/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153333241 | Dexcom, Inc. | $21.45 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.